Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist

The tail suspension test: A new method for screening antidepressants in mice

1985 • 3,300 citations

PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORS

1997 • 3,070 citations

Behavioural despair in rats: A new model sensitive to antidepressant treatments

1978 • 3,035 citations

Molecular Diversity of Glutamate Receptors and Implications for Brain Function

1992 • 2,535 citations

Basic and Clinical Pharmacology

1982 • 2,009 citations

Basic and clinical pharmacology

1988 • 1,173 citations

The olfactory bulbectomized rat as a model of depression: An update

1997 • 654 citations

Glutamate in CNS disorders as a target for drug development: an update

1998 • 423 citations

Activation of Metabotropic Glutamate Receptor 5 Has Direct Excitatory Effects and Potentiates NMDA Receptor Currents in Neurons of the Subthalamic Nucleus

2000 • 414 citations

Glutamate and Depression

2003 • 404 citations

3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]- pyridine: A Potent and Highly Selective Metabotropic Glutamate Subtype 5 Receptor Antagonist with Anxiolytic Activity

2002 • 396 citations

Antidepressants for the new millennium

1999 • 358 citations

Potential anxiolytic‐ and antidepressant‐like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist

2001 • 311 citations

Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons

2001 • 305 citations

Antidepressant and anxiolytic‐like effects in mice lacking the group III metabotropic glutamate receptor mGluR7

2003 • 257 citations

MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity

2003 • 248 citations

Selective mGluR5 antagonists MPEP and SIB‐1893 decrease NMDA or glutamate‐mediated neuronal toxicity through actions that reflect NMDA receptor antagonism

2000 • 194 citations

Positive allosteric modulation of the human metabotropic glutamate receptor 4 (hmGluR4) by SIB‐1893 and MPEP

2003 • 174 citations

The Behavioral Profile of the Potent and Selective mGlu5 Receptor Antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in Rodent Models of Anxiety

2004 • 159 citations

Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats

2002 • 154 citations

Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges

2001 • 141 citations

Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats

2003 • 131 citations

Potentiation of NMDA and AMPA responses by the specific mGluR5 agonist CHPG in spinal cord motoneurons

1999 • 109 citations

A review of the relevance and validity of olfactory bulbectomy as a model of depression

2003 • 100 citations

Behavioural and Neurochemical Effects of Dizocilpine in the Olfactory Bulbectomized Rat Model of Depression

1997 • 90 citations

Evidence that the metabotropic glutamate receptor 5 antagonist MPEP may act as an inhibitor of the norepinephrine transporter in vitro and in vivo

2003 • 73 citations

Activity of litoxetine and other serotonin uptake inhibitors in the tail suspension test in mice

1992 • 68 citations

Antidepressant-like effect of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist in the olfactory bulbectomized rats

2002 • 58 citations

A role for glutamate in the treatment of anxiety and depression: Focus on group I metabotropic glutamate (mGlu) receptors

2002 • 23 citations